Dublin, Jan. 24, 2017 -- Research and Markets has announced the addition of the "Implantable Medical Devices Market Analysis and Trends - Product, Material - Forecast to 2025" report to their offering.
The Global Implantable Medical Devices Market is poised to grow at a CAGR of around 5.4% over the next decade to reach approximately $54.28 billion by 2025
Some of the prominent trends that the market is witnessing include 3D medical printing is expected to develop and find in several areas of medicine, Integrated circuits for next generation implantable medical devices , Growth of Biocompatible Silicone in implantable medical devices & Growth opportunities/Investment Opportunities.
Scope of the Report
- Based on Product the market is categorized into Dental Implants, Orthopedic Implants, Cardiovascular Implants, Breast implants, Intraocular lens , Orthobiologics, and Other implantable products.
- The Orthopedic Implants segment is further divided into Reconstructive Joint Replacement, Spinal Implants and Trauma fixation implants.
- Cardiovascular Implants segment is further categorized into Pacing Devices, Implantable Cardiac Pacemakers (ICPs), Cardiac Stents, Implantable Hemodynamic Monitors (IHMs), Implantable Heart Monitors and Drug-Eluting Stents.
- Other implants segment includes Gynecological Devices, Drug Implants, Otolaryngeal Implants, Cosmetic Implants, Gastroenterological Implants, Hormonal Implants and Urological Implants.
- Orthobiologics is further classified as Hyaluronic Acid, Bone Substitutes, Bone Growth Factors, Bone Cement and Tissue Implants.
Depending on the Material the market is segregated by Metals, Biologics, Ceramics and Polymers. - The Metal segment is further sub divided as Co-Cr Alloy, Stainless Steel, Titanium, Titanium Alloy and Zirconium.
- The Ceramics is fragmented as Zirconia ceramics (ZrO 2). The Polymers market is further as Biodegradable Polymers.
- The End User segment market is fragmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Clinics.
Companies Mentioned
- AQTIS Medical
- Abbott Laboratories
- Allergan Plc
- Arion Laboratories
- Bausch & Lomb Incorporated
- Bioha Laboratories
- Biomet Incorporated
- Edwards Lifesciences Corporation
- Establishment Labs
- Guangzhou Wanhe Plastic Material
- Hans Biomed
- Ivoclar Vivadent
- Johnson & Johnson
- Medtronic Incorporated
- Merck & Company Incorporated
- Nobel Biocare
- POLYTECH Health & Aesthetics
- St. Jude Medical Incorporated
- Straumann Group
- Stryker Corporation
- Synthes Incorporated
- Zimmer Holdings Incorporated
For more information about this report visit http://www.researchandmarkets.com/research/bpq4g4/implantable
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



